Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5252622 | 0.84 | MGLL (0.50) | MGLL | |
| SCHEMBL2349053 | 0.71 | CTSA (0.41) | ADORA3ADORA1 | |
| SCHEMBL2349057 | 0.71 | CTSA (0.41) | ADORA3ADORA1 | |
| SCHEMBL9460406 | 0.71 | FAAH (0.60) | MGLLFAAH | |
| SCHEMBL14736076 | 0.69 | IDO1 (0.55) | ADORA3ADORA1 | |
| SCHEMBL27564494 | 0.69 | TLR8 (0.41) | ADORA3ADORA1 | |
| SCHEMBL27564493 | 0.69 | TLR8 (0.41) | ADORA3ADORA1 | |
| SCHEMBL25277427 | 0.69 | MGLL (0.64) | MGLL | |
| SCHEMBL30433811 | 0.69 | MGLL (0.56) | MGLL | |
| SCHEMBL14736555 | 0.69 | CDK4 (0.44) | ADORA3ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050038087-A1 | Derivatives of heterocycles with 5 members, their preparation and their use as medicaments | IPSEN PHARMA S.A.S. (FR) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038087-A1 | Derivatives of heterocycles with 5 members, their preparation and their use as medicaments | OXER1, OPRL1, OPRK1 | MGLL 3702/4885ADORA3 676/4885ADORA1 610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.